LCM
GSK icon

Logan Capital Management’s GSK GSK Stock Holding History

Logan Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-125,740
Closed -$6.94M – 543
2026
Q1 		$6.94M Buy
+125,740
New +$6.81M 0.3% 93

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Logan Capital Management's GSK Position: Q2 2026 in Review

Logan Capital Management opened a new position in GSK (GSK) in Q2 2026: 141,076 shares worth $7.4M. The stake represents 0.28% of the portfolio and ranks #100 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in GSK as recently as Q4 2025.

Logan Capital Management first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.3M in Q1 2015. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Logan Capital Management held 141,076 shares of GSK worth $7.4M as of Q2 2026.
  • GSK was a new Logan Capital Management position in Q2 2026.
  • GSK made up 0.28% of Logan Capital Management's portfolio in Q2 2026, its #100 holding.
  • Logan Capital Management first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
  • Logan Capital Management's GSK position peaked at $13.3M in Q1 2015.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.